After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun ...

Incyte's infringement lawsuit is claiming that Sun Pharma's drug infringes a US patent (No. 9,662,335) it holds on the use of ...

Shares in many large drugmakers initially fell Wednesday on the president's threat, only to rebound later when he announced a ...

A consumer-driven weight loss market could put pharma at greater risk if a recession hits; the continued turmoil at FDA and other HHS agencies magnifies the uncertainty facing the industry; Lilly ...

Former top legal executives at large companies including Microsoft, Intel and Eli Lilly submitted a legal brief on Tuesday ...

GCs, bar associations, and litigation firms are among the latest to file amicus briefs supporting Perkins Coie in its legal ...

A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...

Eli Lilly says Indianapolis-based Premier Weight Loss is cracking open auto-injector pens containing its blockbuster drug and ...

The Michigan Supreme Court, after hearing oral arguments last year on the state attorney general’s desire to investigate Eli ...

Eli Lilly and Co. is suing an Indianapolis-based weight-loss clinic it says is improperly selling Lilly’s hugely popular ...

Pharma and biotech companies are breathing a sigh of relief after the tariffs announced by President Donald Trump Wednesday afternoon excludes pharmaceuticals.

Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...